CD79A and infection: Studies on humoral response have demonstrated that individuals with prior infections maintain higher levels of RBD-specific MBCs, as well as RBD-specific IgG and IgA, compared to those without prior infection, 3 and 6 months after receiving a two-dose vaccination [78].